<< HHS announces grants to help them find eligible uninsured children for Medicaid or CHIP | Incyte raises $400.0 million through private placement >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Filipino | Русский | Svenska | Polski

Incyte declares closure of public offering shares

Published on October 1, 2009 at 2:56 AM · No Comments

Incyte Corporation (Nasdaq:INCY) today announced the closing of its public offering of 20,700,000 shares of its common stock at a price to the public of $6.75 per share, which includes 2,700,000 shares sold upon exercise by the underwriters of their option to purchase additional shares. The net proceeds to Incyte from the offering are approximately $132.0 million, after deducting the underwriting discount and estimated offering expenses.

The Company intends to use the net proceeds of this offering for general corporate purposes, including research and development activities.

Goldman, Sachs & Co. acted as sole book-running manager of this offering. Morgan Stanley & Co. Incorporated and J.P. Morgan Securities Inc. acted as co-managers.

The shares were issued pursuant to an effective shelf registration statement. Printed copies of the prospectus supplement and prospectus relating to the offering may be obtained from Goldman, Sachs & Co. (Attn: Prospectus Department, 85 Broad Street, New York, New York 10004, Telephone: 1-866-471-2526, Fax: 212-902-9316 or Email at prospectus-ny@ny.email.gs.com).

http://www.incyte.com/

Posted in:

Tags: , ,

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading